RecallRadar

FDA Device recall Z-2335-2025

VITROS Chemistry Products Ca Slides

On 2025-08-27 the FDA classified a Class II recall of VITROS Chemistry Products Ca Slides by Ortho Clinical Diagnostics, citing generations 67 and above of VITROS Ca Slides are experiencing an increased occurrence of Condition Code TH4-63J during calibration on VITROS XT 3400 and VITROS XT 7600 Systems, ca….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-2335-2025
ClassificationClass II
Statusongoing
Initiated2025-07-09
Published2025-08-27
Last updated2026-09-13 11:57 UTC
CompanyOrtho Clinical Diagnostics
DistributionUS

Product

VITROS Chemistry Products Ca Slides; Catalog Number: 145 0261;

Reason

Generations 67 and above of VITROS Ca Slides are experiencing an increased occurrence of Condition Code TH4-63J during calibration on VITROS XT 3400 and VITROS XT 7600 Systems, causing calibration failures that delay calcium test results and potentially impact patient management. The imaging reflectometer algorithm detects excessive "spikes" (imperfections) in slide images and generates the TH4-63J condition code when the threshold of 600 spikes is exceeded. Updated analysis revealed a 19-fold increase in failure rates from 0.0043% (2024 baseline) to 0.082% for Generation 67+ slides in 2025, with 100% of calibrator failures occurring at the lowest concentration level. This can result in delayed diagnosis and treatment of conditions such as hypercalcemic crisis, parathyroid disorders, and other calcium-related emergencies requiring urgent intervention.

Identifiers

code_infoCatalog Number: 145 0261; UDI-DI: 10758750009114; Affected GENs: 67 and above;

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:57 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2335-2025%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.